GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Asymptote Ltd is part of GE Healthcare Life Sciences. Asymptote specialises in the development and supply of cryo-chain equipment and consumables for use in regenerative medicine and other biological applications.
|Telephone:||+44 (0)330 660 0320|
|Address:||GE Healthcare, Sovereign House, Cambridge|
|Membership type:||Corporate 51+ (£1,000+VAT pa)|
The Asymptote product portfolio comprises hardware, software and consumables. Our VIA Freeze range of liquid nitrogen-free controlled rate freezers and the first in a series of automated, dry conduction thawers - the CellSeal Automated Thawing System - are available today. The VIA Thaw for cryobags and vials will be released soon. All Asymptote's hardware products integrate with my.Cryochain to standardize and audit remote processes from any web-browser. Together these form a complete cryochain platform: an integrated end-to-end solution for most vial and container types. More products are in development, including IceStart, an ice nucleator to ensure consistent freezing in multiwell plates.
Asymptote’s digitally-enabled cryogenic cold chain technology supports safe manufacture and delivery of cellular therapies
2 May 2017Read in full
GE Healthcare acquires Asymptote for complete, digitally-enabled cryogenic cold chain technology supporting safe manufacture and delivery of cellular therapies. The acquisition further strengthens GE Healthcare’s cell therapy portfolio with a suite of technologies for the cryopreservation of cellular materials
10 April 2017Read in full
Asymptote Ltd, specialists in cryochain technology for advanced medicines, has announced the commercial launch of my.Cryochain, a software platform developed specifically to give centralised control of the cryogenic cold chain for cellular therapies.
29 November 2016Read in full
Indianapolis, US, and Cambridge UK, 29th November 2016 Cook Regentec, focused on developing research and clinical tools to advance regenerative medicine therapies from the lab to the patient, and Asymptote Ltd., specialists in cryochain for regenerative medicine, today announced the launch of the CellSeal® Automated Thawing System.
29 November 2016Read in full
The Cell Therapy Catapult and Asymptote, a leading specialist in cryopreservation based in Cambridge, are combining forces to advance the development of a novel point-of-care Thawing System for Cell Based Therapies.
1 May 2015Read in full
Cambridge-based cryopreservation specialists Asymptote Ltd will launch its unique range of liquid nitrogen free controlled rate freezers specially designed for the needs of regenerative medicine at the annual meeting of the International Society for Cellular Therapy (ISCT) to be held in Paris.
23 April 2014Read in full
Cambridge-based cryopreservation specialists Asymptote Ltd, has been awarded a grant from the Technology Strategy Board to develop ways of improving the storage of live vaccines for use in the third world. Asymptote is developing ultra low temperature storage equipment which could help prevent vaccines from being discarded unnecessarily.
5 June 2013Read in full
Embedded Senior Software Engineer
GE is the world's Digital Industrial Company, transforming industry with software-defined machines and solutions that are connec...
Software Development Engineer - Customer Solutions
Role Summary We are searching for an enthusiast to help our customers get more from our SaaS automation platform. The success...